Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-Assisted Psychotherapy for PTSD (MP18)
NCT04030169Phase 2Completed
- Start
- Jun 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of midomafetamine in post-traumatic stress disorder (PTSD). Started Jun 2020; status: completed.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04030169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04030169.